4-[2-(4-Fluorophenyl)-4-(1-propyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-pyrrol-3-yl]pyridine

ID: ALA1092617

PubChem CID: 9928889

Max Phase: Preclinical

Molecular Formula: C23H24FN3

Molecular Weight: 361.46

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCCN1CC=C(c2c[nH]c(-c3ccc(F)cc3)c2-c2ccncc2)CC1

Standard InChI:  InChI=1S/C23H24FN3/c1-2-13-27-14-9-17(10-15-27)21-16-26-23(19-3-5-20(24)6-4-19)22(21)18-7-11-25-12-8-18/h3-9,11-12,16,26H,2,10,13-15H2,1H3

Standard InChI Key:  XGLAAPICLZABCU-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 27 30  0  0  0  0  0  0  0  0999 V2000
   -2.7144   -8.1747    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0328   -8.6381    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3816   -8.1331    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6605   -7.3573    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4845   -7.3836    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9054   -6.6766    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4987   -5.9567    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9187   -5.2466    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7453   -5.2552    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1501   -5.9798    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7278   -6.6870    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4255   -8.5914    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1437   -8.1815    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8556   -8.5984    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8506   -9.4251    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1277   -9.8330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4187   -9.4138    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2417   -6.6445    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4150   -6.6497    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0006   -5.9403    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4060   -5.2211    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2328   -5.2159    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6529   -5.9299    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5624   -9.8437    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.0123   -4.5091    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8381   -4.5154    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2565   -3.8034    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  6  7  2  0
 13 14  1  0
  2  3  1  0
 14 15  2  0
  7  8  1  0
 15 16  1  0
  3  4  2  0
 16 17  2  0
 17 12  1  0
  1 12  1  0
 18 19  2  0
  8  9  2  0
  4  5  1  0
  9 10  1  0
  5  1  2  0
 10 11  2  0
 11  6  1  0
 18 23  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
  4 18  1  0
  5  6  1  0
 15 24  1  0
  1  2  1  0
 21 25  1  0
 25 26  1  0
 12 13  2  0
 26 27  1  0
M  END

Associated Targets(Human)

Blood (2950 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 361.46Molecular Weight (Monoisotopic): 361.1954AlogP: 5.38#Rotatable Bonds: 5
Polar Surface Area: 31.92Molecular Species: BASEHBA: 2HBD: 1
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 9.26CX LogP: 4.45CX LogD: 2.59
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.66Np Likeness Score: -0.68

References

1. Nakao A, Ohkawa N, Nagasaki T, Kagari T, Doi H, Shimozato T, Ushiyama S, Aoki K..  (2010)  Tetrahydropyridine derivatives with inhibitory activity on the production of proinflammatory cytokines: part 2.,  20  (8): [PMID:20346666] [10.1016/j.bmcl.2010.03.022]
2. Nakao A, Ohkawa N, Nagasaki T, Kagari T, Doi H, Shimozato T, Ushiyama S, Aoki K..  (2010)  Tetrahydropyridine derivatives with inhibitory activity on the production of proinflammatory cytokines: part 3.,  20  (16): [PMID:20637613] [10.1016/j.bmcl.2010.06.122]

Source